AptarGroup, Inc. (NYSE:ATR) today reported record third quarter revenues
and earnings per share. AptarGroup also announced that its Board of
Directors authorized the repurchase of up to $350 million of the
Company’s common stock. This new authorization replaces all previous
authorizations.
Third Quarter 2014 Summary
-
Reported sales increased 5% to $652 million (core sales excluding
currency effects increased 6%)
-
Sales increased in each business segment and each geographic region
-
Food + Beverage sales surged 25% over the prior year supported by
strong growth in Asia and Latin America and increased custom tooling
sales
-
Reported earnings per share rose 9% to $0.73 compared to $0.67 in
the prior year
-
Compared to previously disclosed earnings per share guidance,
earnings per share were negatively impacted by changes in currency
exchange rates by approximately $0.02 per share
-
Current year earnings per share included a negative impact of $0.01
per share related to tax provision items and prior year earnings per
share included a negative impact of $0.03 per share related to
restructuring initiatives
-
Comparable year on year adjusted earnings per share rose 6% to
$0.74 compared to $0.70 in the prior year
THIRD QUARTER RESULTS
For the quarter ended September 30, 2014, reported sales increased 5% to
$652 million from $624 million a year ago. Changes in currency exchange
rates negatively impacted sales growth by approximately 1%.
|
|
Third Quarter Segment Sales Analysis
(Change Over Prior Year)
|
|
|
|
|
|
|
Beauty +
|
|
|
|
|
|
Food +
|
|
|
Total
|
|
|
|
|
|
|
Home
|
|
|
Pharma
|
|
|
Beverage
|
|
|
AptarGroup
|
|
Product Sales (including tooling)
|
|
|
|
|
2%
|
|
|
5%
|
|
|
25%
|
|
|
6%
|
|
Currency Effects
|
|
|
|
|
-1%
|
|
|
-1%
|
|
|
---
|
|
|
-1%
|
|
Total Reported Growth
|
|
|
|
|
1%
|
|
|
4%
|
|
|
25%
|
|
|
5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commenting on the quarter, Stephen Hagge, President and CEO, said, “Our
diversified business model continues to be a strength of Aptar. Sales
increased in each business segment and each geographic region. Compared
to the prior year, our sales in Latin America and Asia grew at a strong
pace. Sales also increased in the U.S. and we saw sales grow in Europe
but at a slower rate than we have seen in recent quarters. Our Beauty +
Home segment, our largest business in terms of revenue, had modest top
line growth due to continued weak demand in the U.S. and more recent
softening conditions in Latin America. However, our Food + Beverage
segment reported exceptional sales growth, particularly in Asia and
Latin America. Our Pharma segment also had a good quarter despite a
difficult comparison to the prior year for our injectables business
which had a very strong third quarter last year.”
Hagge continued, “We are continuing to implement cost saving measures in
our Beauty + Home business though segment income remained under pressure
primarily due to continued soft conditions in the U.S. and some start-up
costs related to our Latin American facilities. Our Pharma and Food +
Beverage segments each reported good growth in segment income that
helped us achieve record third quarter earnings per share.”
AptarGroup reported earnings per share of $0.73 compared to $0.67 per
share a year ago. Current quarter earnings per share included a negative
impact of approximately $0.01 per share primarily related to tax charges
stemming from a legal reorganization in Europe that were mostly offset
by foreign tax credits. Prior year earnings per share included a
negative impact of approximately $0.03 per share related to AptarGroup’s
European restructuring initiative that was substantially completed at
the end of 2013.
YEAR-TO-DATE RESULTS
For the nine months ended September 30, 2014, reported sales increased
6% to $2 billion from $1.88 billion a year ago. Changes in currency
exchange rates did not have a significant impact on the sales growth.
|
|
Nine Months Year-to-Date Segment Sales Analysis
(Change Over Prior Year)
|
|
|
|
|
|
|
Beauty +
|
|
|
|
|
|
Food +
|
|
|
Total
|
|
|
|
|
|
|
Home
|
|
|
Pharma
|
|
|
Beverage
|
|
|
AptarGroup
|
|
Product Sales (including tooling)
|
|
|
|
|
4%
|
|
|
7%
|
|
|
12%
|
|
|
6%
|
|
Currency Effects
|
|
|
|
|
---
|
|
|
2%
|
|
|
---
|
|
|
---
|
|
Total Reported Growth
|
|
|
|
|
4%
|
|
|
9%
|
|
|
12%
|
|
|
6%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hagge commented on the year-to-date results, “Despite some challenges we
have faced this year, including soft conditions in several markets in
the U.S., core sales have increased by six percent. Demand for our
innovative dispensing and sealing solutions has been broad-based. We
have increased core sales in each geographic region and end market with
the sole exception being the injectables market which is down slightly
for the year. We continued to leverage successes from region to region
such as our recent new market penetrations in liquid concentrated
flavorings in Europe and infant formula in Asia. Earnings have also
increased compared to the prior year even though we faced headwinds
including foreign currency transaction and facility start-up costs in
Latin America and suboptimum operating performance at certain U.S.
facilities.”
AptarGroup reported earnings per share of $2.21 compared to $1.98 a year
ago. Prior year earnings per share included a negative effect of charges
related to the European restructuring plan of approximately $0.12 per
share.
OUTLOOK
Commenting on AptarGroup’s outlook, Hagge said, “We anticipate that the
fourth quarter will be challenging. Consistent with recent macroeconomic
indicators, certain markets in Latin America and Europe are expected to
be weaker than recent quarters. We do not see the U.S. growth trajectory
in our markets changing dramatically. In addition, we face a difficult
comparison to the strong fourth quarter of the prior year when we posted
double-digit top-line growth and foreign currency exchange rates were
much more favorable than they are today. Despite these challenges, the
fundamentals of our end markets have not changed and we will stay
focused on our strategic approach to these markets as we invest in
innovative solutions that help our customers grow their businesses.”
AptarGroup expects earnings per share for the fourth quarter using a 33%
effective tax rate to be in the range of $0.58 to $0.63 per share
compared to $0.54 per share reported in the prior year. Assuming a
comparable foreign currency exchange rate environment and excluding the
negative effects of charges related to the European restructuring plan
and certain tax related items, comparable earnings per share for the
prior year would have been $0.60 per share. A reconciliation of the
prior year fourth quarter adjusted net income per diluted share is
provided in the tables that accompany this press release.
SHARE REPURCHASE AUTHORIZATION AND CASH DIVIDEND
The Board of Directors approved a new share repurchase authorization of
up to $350 million of common stock. This new authorization replaces
previous authorizations. AptarGroup may repurchase shares through the
open market, privately negotiated transactions or other programs,
subject to market conditions. As previously reported, the Board declared
a quarterly cash dividend of $0.28 per share. The payment date is
November 26, 2014, to stockholders of record as of November 5, 2014.
“Our strong financial condition enables us to invest in our business and
return cash to shareholders through share repurchases and dividends. The
new $350 million repurchase authorization allows us to pursue a more
aggressive approach to our share repurchase program,” stated Hagge.
OPEN CONFERENCE CALL
There will be a conference call on Friday, October 31, 2014 at 8:00 a.m.
Central Time to discuss AptarGroup’s third quarter results for 2014. The
call will last approximately one hour. Interested parties are invited to
listen to a live webcast by visiting the Investor Relations page at www.aptar.com.
Replay of the conference call can also be accessed on the Investor
Relations page of the website.
AptarGroup, Inc. is a leading global supplier of a broad range of
innovative dispensing solutions for the beauty, personal care, home
care, prescription drug, consumer health care, injectables, food, and
beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois,
with manufacturing facilities in North America, Europe, Asia and South
America. For more information, visit www.aptar.com.
This press release contains forward-looking statements. Words such as
“expects,” “anticipates,” “believes,” “estimates,” and other similar
expressions or future or conditional verbs such as “will,” “should,”
“would” and “could” are intended to identify such forward-looking
statements. Forward-looking statements are made pursuant to the safe
harbor provisions of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 and are based on
management’s beliefs as well as assumptions made by and information
currently available to management. Accordingly, AptarGroup’s actual
results may differ materially from those expressed or implied in such
forward-looking statements due to known or unknown risks and
uncertainties that exist including, but not limited to, economic,
environmental or political conditions in the various markets and
countries in which AptarGroup operates; changes in customer and/or
consumer spending levels; financial conditions of customers and
suppliers; consolidations within our customer or supplier bases;
fluctuations in the cost of raw materials, components and other input
costs; the Company’s ability to increase prices, contain costs and
improve productivity; changes in capital availability or cost, including
interest rate fluctuations; the competitive marketplace; fiscal and
monetary policies and other regulations; inflationary pressures and
changes in foreign currency exchange rates; direct or indirect
consequences of acts of war or terrorism; and labor relations. For
additional information on these and other risks and uncertainties,
please see AptarGroup’s filings with the Securities and Exchange
Commission, including its Form 10-K’s and Form 10-Q’s. Readers are
cautioned not to place undue reliance on forward-looking statements.
AptarGroup undertakes no obligation to update any forward-looking
statements, whether as a result of new information, future events or
otherwise.
|
|
|
|
APTARGROUP, INC.
|
Condensed Consolidated Financial Statements (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
(In Thousands, Except Per Share Data)
|
CONSOLIDATED STATEMENTS OF INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
2014
|
|
2013
|
|
|
2014
|
|
2013
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales
|
|
|
$
|
651,942
|
|
|
$
|
623,644
|
|
|
|
$
|
1,998,624
|
|
|
$
|
1,882,718
|
|
Cost of Sales (exclusive of depreciation
|
|
|
|
|
|
|
|
|
|
|
shown below)
|
|
|
|
443,520
|
|
|
|
424,011
|
|
|
|
|
1,347,982
|
|
|
|
1,273,848
|
|
Selling, Research & Development and
|
|
|
|
|
|
|
|
|
|
|
Administrative
|
|
|
|
91,649
|
|
|
|
86,917
|
|
|
|
|
294,809
|
|
|
|
269,335
|
|
Depreciation and Amortization (1)
|
|
|
|
38,158
|
|
|
|
37,222
|
|
|
|
|
113,871
|
|
|
|
112,007
|
|
Restructuring Initiatives
|
|
|
|
-
|
|
|
|
2,180
|
|
|
|
|
-
|
|
|
|
8,758
|
|
Operating Income
|
|
|
|
78,615
|
|
|
|
73,314
|
|
|
|
|
241,962
|
|
|
|
218,770
|
|
Other Income/(Expense):
|
|
|
|
|
|
|
|
|
|
|
Interest Expense
|
|
|
|
(5,332
|
)
|
|
|
(4,841
|
)
|
|
|
|
(15,459
|
)
|
|
|
(15,364
|
)
|
Interest Income
|
|
|
|
1,386
|
|
|
|
576
|
|
|
|
|
3,449
|
|
|
|
2,271
|
|
Equity in results of affiliates
|
|
|
|
(124
|
)
|
|
|
(286
|
)
|
|
|
|
(1,868
|
)
|
|
|
(609
|
)
|
Miscellaneous, net
|
|
|
|
(429
|
)
|
|
|
(437
|
)
|
|
|
|
(582
|
)
|
|
|
(1,070
|
)
|
Income before Income Taxes
|
|
|
|
74,116
|
|
|
|
68,326
|
|
|
|
|
227,502
|
|
|
|
203,998
|
|
Provision for Income Taxes
|
|
|
|
25,496
|
|
|
|
23,094
|
|
|
|
|
77,390
|
|
|
|
68,908
|
|
Net Income
|
|
|
$
|
48,620
|
|
|
$
|
45,232
|
|
|
|
$
|
150,112
|
|
|
$
|
135,090
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (Income)/Loss Attributable to Noncontrolling Interests
|
|
|
|
(25
|
)
|
|
|
32
|
|
|
|
|
(52
|
)
|
|
|
5
|
|
Net Income Attributable to AptarGroup, Inc.
|
|
|
$
|
48,595
|
|
|
$
|
45,264
|
|
|
|
$
|
150,060
|
|
|
$
|
135,095
|
|
Net Income Attributable to AptarGroup, Inc. Per Common Share:
|
|
|
|
|
|
|
|
|
Basic
|
|
|
$
|
0.75
|
|
|
$
|
0.68
|
|
|
|
$
|
2.30
|
|
|
$
|
2.04
|
|
Diluted
|
|
|
$
|
0.73
|
|
|
$
|
0.67
|
|
|
|
$
|
2.21
|
|
|
$
|
1.98
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Numbers of Shares Outstanding:
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
64,886
|
|
|
|
66,092
|
|
|
|
|
65,225
|
|
|
|
66,222
|
|
Diluted
|
|
|
|
66,845
|
|
|
|
67,986
|
|
|
|
|
67,761
|
|
|
|
68,273
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Depreciation and Amortization for the quarter and year-to-date
ended September 30, 2013 included approximately $0.5 million and
$1.5 million, respectively, of accelerated depreciation related to
the European restructuring plan.
|
|
|
APTARGROUP, INC.
|
Condensed Consolidated Financial Statements (Unaudited)
|
(continued)
|
(In Thousands)
|
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2014
|
|
|
|
|
December 31, 2013
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and Equivalents
|
|
|
|
|
$
|
347,394
|
|
|
|
|
$
|
309,861
|
Receivables, net
|
|
|
|
|
|
468,182
|
|
|
|
|
|
438,221
|
Inventories
|
|
|
|
|
|
340,952
|
|
|
|
|
|
353,159
|
Other Current Assets
|
|
|
|
|
|
102,644
|
|
|
|
|
|
97,170
|
Total Current Assets
|
|
|
|
|
|
1,259,172
|
|
|
|
|
|
1,198,411
|
Net Property, Plant and Equipment
|
|
|
|
|
|
831,014
|
|
|
|
|
|
864,662
|
Goodwill, net
|
|
|
|
|
|
339,275
|
|
|
|
|
|
358,865
|
Other Assets
|
|
|
|
|
|
69,778
|
|
|
|
|
|
75,824
|
Total Assets
|
|
|
|
|
$
|
2,499,239
|
|
|
|
|
$
|
2,497,762
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Obligations
|
|
|
|
|
$
|
246,530
|
|
|
|
|
$
|
139,770
|
Accounts Payable and Accrued Liabilities
|
|
|
|
|
|
385,343
|
|
|
|
|
|
403,051
|
Total Current Liabilities
|
|
|
|
|
|
631,873
|
|
|
|
|
|
542,821
|
Long-Term Obligations
|
|
|
|
|
|
355,583
|
|
|
|
|
|
354,814
|
Deferred Liabilities
|
|
|
|
|
|
100,905
|
|
|
|
|
|
119,819
|
Total Liabilities
|
|
|
|
|
|
1,088,361
|
|
|
|
|
|
1,017,454
|
|
|
|
|
|
|
|
|
|
|
|
AptarGroup, Inc. Stockholders' Equity
|
|
|
|
|
|
1,410,280
|
|
|
|
|
|
1,479,757
|
Noncontrolling Interests in Subsidiaries
|
|
|
|
|
|
598
|
|
|
|
|
|
551
|
Total Equity
|
|
|
|
|
|
1,410,878
|
|
|
|
|
|
1,480,308
|
|
|
|
|
|
|
|
|
|
|
|
Total Liabilities and Equity
|
|
|
|
|
$
|
2,499,239
|
|
|
|
|
$
|
2,497,762
|
|
|
APTARGROUP, INC.
|
Condensed Consolidated Financial Statements (Unaudited)
|
(continued)
|
(In Thousands)
|
SEGMENT INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2014
|
|
2013
|
|
|
2014
|
|
2013
|
NET SALES
|
|
|
|
|
|
|
|
|
|
|
Beauty + Home
|
|
|
$
|
378,905
|
|
|
$
|
376,051
|
|
|
|
$
|
1,155,367
|
|
|
$
|
1,114,507
|
|
Pharma
|
|
|
|
179,191
|
|
|
|
172,270
|
|
|
|
|
569,230
|
|
|
|
524,070
|
|
Food + Beverage
|
|
|
|
93,846
|
|
|
|
75,323
|
|
|
|
|
274,027
|
|
|
|
244,141
|
|
Total Net Sales
|
|
|
$
|
651,942
|
|
|
$
|
623,644
|
|
|
|
$
|
1,998,624
|
|
|
$
|
1,882,718
|
|
|
|
|
|
|
|
|
|
|
|
|
SEGMENT INCOME (1)
|
|
|
|
|
|
|
|
|
|
|
Beauty + Home
|
|
|
$
|
25,399
|
|
|
$
|
30,943
|
|
|
|
$
|
80,378
|
|
|
$
|
85,697
|
|
Pharma
|
|
|
|
49,314
|
|
|
|
44,737
|
|
|
|
|
154,589
|
|
|
|
141,154
|
|
Food + Beverage
|
|
|
|
11,713
|
|
|
|
7,688
|
|
|
|
|
33,209
|
|
|
|
28,102
|
|
Restructuring Initiatives & Related Depreciation (2)
|
|
|
|
-
|
|
|
|
(2,664
|
)
|
|
|
|
-
|
|
|
|
(10,257
|
)
|
Corporate and Other
|
|
|
|
(8,364
|
)
|
|
|
(8,113
|
)
|
|
|
|
(28,664
|
)
|
|
|
(27,605
|
)
|
Total Income Before Interest and Taxes
|
|
|
$
|
78,062
|
|
|
$
|
72,591
|
|
|
|
$
|
239,512
|
|
|
$
|
217,091
|
|
Interest Expense, Net
|
|
|
|
(3,946
|
)
|
|
|
(4,265
|
)
|
|
|
|
(12,010
|
)
|
|
|
(13,093
|
)
|
Income before Income Taxes
|
|
|
$
|
74,116
|
|
|
$
|
68,326
|
|
|
|
$
|
227,502
|
|
|
$
|
203,998
|
|
|
|
|
|
|
|
|
|
|
|
|
SEGMENT INCOME AS % OF NET SALES
|
|
|
|
|
|
|
|
|
|
|
Beauty + Home
|
|
|
|
6.7
|
%
|
|
|
8.2
|
%
|
|
|
|
7.0
|
%
|
|
|
7.7
|
%
|
Pharma
|
|
|
|
27.5
|
%
|
|
|
26.0
|
%
|
|
|
|
27.2
|
%
|
|
|
26.9
|
%
|
Food + Beverage
|
|
|
|
12.5
|
%
|
|
|
10.2
|
%
|
|
|
|
12.1
|
%
|
|
|
11.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Condensed Consolidated Financial Statements:
|
|
|
|
|
|
|
|
(1) - The Company evaluates performance of its business units and
allocates resources based upon segment income defined as earnings
before net interest expense, certain corporate expenses,
restructuring initiatives and related depreciation, and income taxes.
|
|
(2) - Restructuring Initiatives & Related Depreciation includes the
following income/(expense) items:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
|
|
|
September 30,
|
Depreciation:
|
|
|
2014
|
|
2013
|
|
|
2014
|
|
2013
|
European Restructuring Plan
|
|
|
$
|
-
|
|
|
$
|
(484
|
)
|
|
|
$
|
-
|
|
|
$
|
(1,499
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring Initiatives:
|
|
|
|
|
|
|
|
|
|
|
European Restructuring Plan
|
|
|
|
-
|
|
|
|
(2,180
|
)
|
|
|
|
-
|
|
|
|
(8,802
|
)
|
Other Initiatives
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
$
|
-
|
|
|
$
|
44
|
|
Total Restructuring Initiatives & Related Depreciation
|
|
|
$
|
-
|
|
|
$
|
(2,664
|
)
|
|
|
$
|
-
|
|
|
$
|
(10,257
|
)
|
|
|
Reconciliation of Adjusted Net Income Per Diluted Share (1)
(Unaudited)
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
December 31,
|
|
|
|
Expected 2014
|
|
2013
|
|
|
|
|
|
|
|
Net Income Attributable to AptarGroup, Inc. Per Diluted Share
|
|
$
|
0.58 - $ 0.63
|
|
$
|
0.54
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
Net effect of items included in the Provision for Income Taxes (2)
|
|
|
-
|
|
|
0.05
|
|
|
Charges related to restructuring initiatives (3)
|
|
|
-
|
|
|
0.05
|
|
|
Foreign currency effects (3) (4)
|
|
|
-
|
|
|
(0.04
|
)
|
|
Adjusted Net Income Per Diluted Share
|
|
$
|
0.58 - $ 0.63
|
|
$
|
0.60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) AptarGroup has presented adjusted net income per diluted
share for the periods covered by this press release, which measure
is a Non-GAAP financial measure. AptarGroup's management believes it
is useful to exclude the impact of certain tax related items
including charges related to French tax regulation and certain other
tax items that were recorded in the fourth quarter of 2013 and
restructuring charges that were recorded in the fourth quarter and
year 2013 from the calculation of net income per diluted share under
U.S. generally accepted accounting principles (GAAP) because such
Non-GAAP financial measure allows for a better comparison of
operating results. This Non-GAAP financial measure should not be
considered in isolation or as a substitute for net income per
diluted share as calculated under GAAP, but should be read in
conjunction with the unaudited condensed consolidated statements of
income and other information presented herein.
|
|
(2) - Items included in the Provision for Income Taxes include an
impact of $0.07 per share related to French Tax regulation that was
enacted in December 2013, and ($0.02) per share related to certain
foreign tax benefits that did not repeat in 2014.
|
|
(3) - Tax effects of the after-tax adjustments noted above are as
follows:
|
Restructuring initiatives
|
|
|
|
$
|
0.01
|
|
|
Foreign currency effects
|
|
|
|
$
|
(0.02
|
)
|
|
|
(4) - Foreign currency effects are approximations of the
adjustment necessary to state the prior year earnings per share
using foreign currency exchange rates as of September 30, 2014.
|
Copyright Business Wire 2014